Suggestions
Jesse Stromeyer
Senior Director, Cell Therapy Marketing
Jesse Stromeyer is a highly accomplished professional with an extensive background in pharmaceutical marketing and management. He holds an MBA in Pharmaceutical Management & Marketing from Rutgers University - Newark and a B.S. in Finance from Rutgers, The State University of New Jersey-New Brunswick. Jesse has held key roles in several prestigious organizations, showcasing his expertise and leadership capabilities.
Currently, Jesse serves as the Senior Director of Cell Therapy Marketing at Iovance Biotherapeutics, Inc., where he plays a crucial role in shaping marketing strategies in the field of cell therapy. Prior to this, he held significant positions at renowned companies such as Bristol Myers Squibb and Novartis.
At Bristol Myers Squibb, Jesse held roles including Director Worldwide Hematology, CAR T, liso-cel CLL indication lead, Preceptorship for OPDIVO Lymphoma Patient Marketing, Associate Director of Digital Delivery, Associate Director of HIV Market Access, Product Manager for ORENCIA Non-Personal Promotion, Associate Product Manager for Orencia Non-Personal Promotion, Orencia Marketing Preceptorship, and Summer Associate for Plavix Global Marketing. These roles underscore Jesse's versatile skill set and his ability to excel in various marketing domains within the pharmaceutical industry.
During his tenure at Novartis, Jesse held the positions of Director for CAR-T (Kymriah) DLBCL Indication Lead and Associate Director for CAR-T Marketing focusing on Lymphoma. Prior to this, he served as the Associate Director of Strategic Market Access Oncology at the same organization, showcasing his expertise in market access strategies.
Jesse's diverse experience spans across marketing, market access, and product management, reflecting his proficiency in developing and implementing comprehensive marketing strategies in the pharmaceutical sector. He has a strong educational foundation complemented by hands-on experience in various facets of pharmaceutical marketing, making him a valuable asset in the industry.